Allscripts Healthcare Solutions (MDRX) Now Covered by Citigroup

Stock analysts at Citigroup began coverage on shares of Allscripts Healthcare Solutions (NASDAQ:MDRX) in a report issued on Thursday. The brokerage set a “buy” rating on the software maker’s stock.

Several other equities research analysts also recently issued reports on MDRX. Cantor Fitzgerald restated a “buy” rating and set a $17.00 price objective on shares of Allscripts Healthcare Solutions in a report on Wednesday, September 27th. Royal Bank of Canada began coverage on Allscripts Healthcare Solutions in a report on Tuesday, September 19th. They set an “outperform” rating and a $17.00 price objective on the stock. Dougherty & Co restated a “buy” rating and set a $16.00 price objective (up from $15.00) on shares of Allscripts Healthcare Solutions in a report on Tuesday, October 3rd. BidaskClub upgraded Allscripts Healthcare Solutions from a “hold” rating to a “buy” rating in a report on Wednesday, December 20th. Finally, Maxim Group restated a “buy” rating and set a $16.00 price objective on shares of Allscripts Healthcare Solutions in a report on Friday, November 3rd. One research analyst has rated the stock with a sell rating, seven have given a hold rating and twelve have assigned a buy rating to the company. Allscripts Healthcare Solutions has an average rating of “Buy” and an average price target of $14.94.

Shares of Allscripts Healthcare Solutions (MDRX) opened at $15.35 on Thursday. The company has a current ratio of 0.98, a quick ratio of 0.98 and a debt-to-equity ratio of 1.20. Allscripts Healthcare Solutions has a twelve month low of $10.24 and a twelve month high of $15.40. The stock has a market capitalization of $2,770.00, a P/E ratio of -13.23, a price-to-earnings-growth ratio of 2.14 and a beta of 1.32.

In related news, SVP James Hewitt sold 36,796 shares of the business’s stock in a transaction that occurred on Friday, December 1st. The stock was sold at an average price of $14.11, for a total transaction of $519,191.56. Following the completion of the transaction, the senior vice president now owns 181,766 shares in the company, valued at approximately $2,564,718.26. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, President Richard J. Poulton sold 15,000 shares of the business’s stock in a transaction that occurred on Friday, December 15th. The shares were sold at an average price of $14.26, for a total value of $213,900.00. Following the transaction, the president now owns 1,351,773 shares of the company’s stock, valued at approximately $19,276,282.98. The disclosure for this sale can be found here. Insiders have sold a total of 56,796 shares of company stock valued at $804,842 in the last 90 days. Insiders own 0.75% of the company’s stock.

Large investors have recently added to or reduced their stakes in the stock. Archford Capital Strategies LLC boosted its position in Allscripts Healthcare Solutions by 6,124.0% during the 2nd quarter. Archford Capital Strategies LLC now owns 6,224 shares of the software maker’s stock valued at $958,000 after purchasing an additional 6,124 shares during the period. Bank of Montreal Can boosted its position in Allscripts Healthcare Solutions by 6.9% during the 2nd quarter. Bank of Montreal Can now owns 10,603 shares of the software maker’s stock valued at $135,000 after purchasing an additional 689 shares during the period. ETF Managers Group LLC acquired a new position in Allscripts Healthcare Solutions during the 2nd quarter valued at approximately $152,000. Sheaff Brock Investment Advisors LLC acquired a new position in Allscripts Healthcare Solutions during the 3rd quarter valued at approximately $174,000. Finally, Crossmark Global Holdings Inc. acquired a new position in Allscripts Healthcare Solutions during the 3rd quarter valued at approximately $187,000.

COPYRIGHT VIOLATION WARNING: “Allscripts Healthcare Solutions (MDRX) Now Covered by Citigroup” was reported by Community Financial News and is the sole property of of Community Financial News. If you are accessing this piece on another website, it was stolen and reposted in violation of U.S. and international copyright and trademark legislation. The original version of this piece can be viewed at https://www.com-unik.info/2018/01/06/allscripts-healthcare-solutions-mdrx-now-covered-by-citigroup.html.

Allscripts Healthcare Solutions Company Profile

Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.

Analyst Recommendations for Allscripts Healthcare Solutions (NASDAQ:MDRX)

What are top analysts saying about Allscripts Healthcare Solutions? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Allscripts Healthcare Solutions and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit